Concord Medical Services Holdings Ltd. engages in the provision of operation of radiotherapy and diagnostic imaging centers. The company is headquartered in Beijing, Beijing and currently employs 595 full-time employees. The company went IPO on 2009-12-11. The firm operates its business through two segments. The Network segment is engaged in providing enterprise customers with integrated oncology-related solutions, including primarily the supply, management and technical support for medical equipment and software solutions, and providing equipment leasing and comprehensive support services. The Hospital segment is engaged in providing a full spectrum of oncology healthcare services to cancer patients across the entire care continuum through its self-owned cancer hospitals and clinics. The firm mainly conducts its business in the domestic market.
Based on comprehensive analyst evaluations, we have synthesized critical insights from expert assessments to outline a cautious outlook for CCM. Analysts note deteriorating fundamentals and challenging market sentiment, indicating potential downside risks in the near term. Following this expert analysis, we adopt a bearish stance on this stock. Our conclusion: CCM is a Sell candidate.
CCM stock price ended at $3.83 on 星期三, after rising 0.52%
On the latest trading day Feb 11, 2026, the stock price of CCM rose by 0.52%, climbing from $3.76 to $3.83. Throughout the session, the stock experienced a volatility of 2.39%, with prices fluctuating between a daily low of $3.76 and a high of $3.85. Alongside this price increase, trading volume also rose by 1.5K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 1.5K shares were traded, amounting to a market value of approximately $166.2M.